IGC vs STE · rev $1.3M vs P/E 25, rev $5.46B
India Globalization Capital Inc (IGC) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
India Globalization Capital Inc (IGC) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported IGC revenue for 2025-03-31 was $1.3M. Net income was -$7.1M. Revenue was down 5.5% from 2024-03-31 to 2025-03-31. IGC currently screens at market cap $24.1M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
IGC currently screens at market cap $24.1M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the IGC and STE stock pages for the full models.
Not investment advice.